For the quarter ending 2026-03-31, REFR had $615,002 increase in cash & cash equivalents over the period. -$759,998 in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -525,365 | -765,563 | -298,508 | -981,513 |
| Depreciation and amortization | 313 | 3,107 | 3,113 | 6,166 |
| Share-based compensation | - | 199,671 | 0 | 175,204 |
| Credit loss expense | - | 30,000 | 0 | 124,253 |
| Deferred revenue | - | - | -66,227 | 71,563 |
| Rou asset amortization | 43,681 | 43,681 | 43,682 | 86,925 |
| Royalty receivables | 136,319 | 66,788 | -164,495 | 2,413 |
| Prepaid expenses and other assets | 121,488 | -41,635 | -48,677 | 67,791 |
| Accounts payable and accrued expenses | 14,802 | 86,975 | -5,997 | -68,297 |
| Operating lease liability | -35,555 | -33,329 | -32,748 | -63,798 |
| Net cash used in operating activities | -759,931 | -465,947 | -143,513 | -719,701 |
| Purchases of fixed assets | 67 | 144 | 373 | 209 |
| Net cash used in investing activities | -67 | -144 | -373 | -209 |
| Net proceeds from exercise of options | - | - | - | 0 |
| Net proceeds from sale of common stock and warrants | 1,375,000 | - | - | - |
| Net cash provided by financing activities | 1,375,000 | - | - | 0 |
| Net increase (decrease) in cash and cash equivalents | 615,002 | -466,091 | -143,886 | -719,910 |
| Cash and cash equivalents at beginning of period | 664,299 | 1,130,390 | 1,994,186 | - |
| Cash and cash equivalents at end of period | 1,279,301 | 664,299 | 1,130,390 | - |
RESEARCH FRONTIERS INC (REFR)
RESEARCH FRONTIERS INC (REFR)